. 2019 Mar 1;9:58–64. doi: 10.1016/j.phro.2019.02.003

Table 1.

Clinical dose criteria for SBRT lymph node oligometastases plans for five fractions as used in the evaluation of the treatment plans, based on the UK SABR consortium guidelines (2016).

Structure	Constraint
PTV	V_35Gy > 95%
PTV	D_max < 47.25 Gy
Bladder	D_0.5cm³ < 38 Gy
Bladder	D_15cm³ < 18.3 Gy
Bowel, Rectum, Sigmoid	D_0.5cm³ < 35 Gy
Bowel, Rectum, Sigmoid	D_10cm³ < 25 Gy